Abstract Oral squamous cell carcinoma (OSCC) accounts for over 90% of oral malignancies and remains associated with high morbidity, recurrence, and poor long-term survival rates. To address these clinical challenges, the development of multifunctional nanotherapeutic systems capable of improving active stability and localized anticancer activity has become a vital focus in oral oncology and dental nanomedicine.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile